The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study

References

• Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316(8):1324–1331. doi:10.1016/j.yexcr.2010.02.04520211171
   PubMed Web of Science ®Google Scholar
• Caceres G, Puskas JA, Magliocco AM. Circulating tumor cells: a window into tumor development and therapeutic effectiveness. Cancer Control. 2015;22(2):167–176. doi:10.1177/10732748150220020726068761
   PubMed Web of Science ®Google Scholar
• Economopoulou P, Kotsantis I, Kyrodimos E, Lianidou ES, Psyrri A. Liquid biopsy: an emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs). Oral Oncol. 2017;74:83–89.29103757
   PubMed Web of Science ®Google Scholar
• Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4(6):448–456. doi:10.1038/nrc137015170447
   PubMed Web of Science ®Google Scholar
• Hristozova T, Konschak R, Stromberger C, et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol. 2011;22(8):1878–1885. doi:10.1093/annonc/mdr13021525401
   PubMed Web of Science ®Google Scholar
• He S, Li P, He S, et al. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results. J Laryngol Otol. 2013;127(8):788–793. doi:10.1017/S002221511300141223835309
   PubMed Web of Science ®Google Scholar
• Jatana KR, Balasubramanian P, Lang JC, et al. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results. Arch Otolaryngol Head Neck Surg. 2010;136(12):1274–1279. doi:10.1001/archoto.2010.22321173379
   PubMedGoogle Scholar
• Balasubramanian P, Lang JC, Jatana KR, et al. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One. 2012;7(7):e42048. doi:10.1371/journal.pone.004204822844540
   PubMed Web of Science ®Google Scholar
• Tinhofer I, Hristozova T, Stromberger C, Keilhoiz U, Budach V. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;83(5):e685–e690. doi:10.1016/j.ijrobp.2012.02.00922583603
   PubMed Web of Science ®Google Scholar
• Li F, Liu J, Song D, Zhang Q, Ding N, He X. Circulating tumor cells in the blood of poorly differentiated nasal squamous cell carcinoma patients: correlation with treatment response. Acta Otolaryngol. 2016;136(11):1164–1167. doi:10.1080/00016489.2016.120186127387761
   PubMed Web of Science ®Google Scholar
• Vo JH, Nei WL, Hu M, et al. Comparison of circulating tumour cells and circulating cell-free Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma undergoing radiotherapy. Sci Rep. 2016;6(1):13. doi:10.1038/s41598-016-0006-328442757
   PubMedGoogle Scholar
• Chen Z, Xu L, Xu X, Yuan C. The clinical value of detecting circulating tumour cells in the peripheral blood of nasopharyngeal carcinoma patients. Oncol Lett. 2018;15(5):6283–6290. doi:10.3892/ol.2018.815529731846
   PubMed Web of Science ®Google Scholar
• Planting A, de Jong M, Jansen P, Kerrebijn J, Smith M, Verweij J. Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer. Eur J Cancer. 2015;41(1):93–97. doi:10.1016/j.ejca.2004.09.022
   Google Scholar
• Galetta D, Giotta F, Rosati G, et al. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: a multicentre phase II study of the Gruppo Oncologico Dell’Italia Meridionale (G.O.I.M.). Anticancer Res. 2005;25(6C):4445–4449.16334124
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Verweij J, Eisenhauer EA, Verweij J. 11 new response evaluation criteria in solid tumors: recist guideline version 1.1. Ejc Suppl. 2009;7(2):5. doi:10.1016/S1359-6349(09)70018-7
   Google Scholar
• Sun B, Liu H, Wang S, Xiang J, Liu X. Prognostic impact of circulating tumor cells in patients with ampullary cancer. J Cell Physiol. 2017;233:7.
   Web of Science ®Google Scholar
• Li J, Wang Z, Chong T, et al. Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion. World J Surg Oncol. 2014;12(1):284. doi:10.1186/1477-7819-12-28425217331
   PubMedGoogle Scholar
• Zhang J, Shi H, Jiang T, Liu Z, Lin PP, Chen N. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma. BMC Cancer. 2018;18(1):1133. doi:10.1186/s12885-018-5034-x30454007
   PubMedGoogle Scholar
• Lin PP. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells. Clin Transl Med. 2015;4(1):38. doi:10.1186/s40169-015-0081-226718583
   PubMedGoogle Scholar
• Nichols AC, Lowes LE, Szeto CC, et al. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head Neck. 2012;34(10):1440–1444. doi:10.1002/hed.2194122076949
   PubMed Web of Science ®Google Scholar
• Buglione M, Grisanti S, Almici C, et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival. Eur J Cancer. 2012;48(16):3019–3026. doi:10.1016/j.ejca.2012.05.00722682019
   PubMed Web of Science ®Google Scholar
• Guney K, Yoldas B, Ozbilim G, Derin AT, Sarihan S, Balkan E. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences? Saudi Med J. 2007;28(2):216–220.17268699
   PubMed Web of Science ®Google Scholar
• Heng DM, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999;86(10):1912–1920. doi:10.1002/(SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S10570413
   PubMed Web of Science ®Google Scholar
• Colnot DR, Nieuwenhuis EJ, Kuik DJ, et al. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res. 2004;10(23):7827–7833. doi:10.1158/1078-0432.CCR-04-109015585614
   PubMed Web of Science ®Google Scholar